See the latest news and media coverage for Sartorius. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life science research and biopharmaceutical technology provider
sartorius.comLast updated
In short: Sartorius reported 8.1% nine-month sales growth and launched a joint TUM biomanufacturing lab
Operational sales revenue rises 8.1 percent in constant currencies to 2,737 million euros, underlying EBITDA margin reaches 30.2 percent, and Executive Board responsibilities change from 2027.
Operational sales revenue grew 7.7% in constant currencies and underlying EBITDA margin rose to 30.3%.
Sales up 6.4% constant currency, EBITDA margin 31.4%, confirms guidance.
Group sales revenue rises 7.5% to 899 million euros. EBITDA margin holds at 29.7%. Full-year guidance confirmed.
Sartorius (XTRA:SRT3) has put several big pieces on the table at once, reporting higher third quarter and nine month sales and net income, reaffirming 2026...
Sartorius Stedim Biotech S.A. has released the results for the third quarter and the first nine months ended September 30, 2026. In the third quarter, ...
The Göttingen-based group Sartorius reports a turnover increase of 8.1 percent to 2.737 billion euros in the first nine months of 2026. At the same time, the...
Sartorius presents new business figures and provides an insight into the development of its most important divisions. The expectations for the full year are also in focus.
Track Sartorius and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.
